Frequently Asked Questions
The market is segmented based on North America Mycoplasma Testing in Clinical Market, By Products (Kits and Reagents, Instruments, Services), Technique (Microbial Culture Techniques/Direct Assay, Polymerase Chain Reaction, ELISA, DNA Staining/Indirect Assay, Enzymatic Methods), Disease Area (Respiratory, Urogenital, Gastrointestinal, Musculoskeletal, Cardiovascular, Others), End User (Diagnostic Laboratories, Hospitals) – Industry Trends and Forecast to 2030.
.
The North America Mycoplasma Testing In Clinical Market size was valued at USD 136.90 USD Million in 2022.
The North America Mycoplasma Testing In Clinical Market is projected to grow at a CAGR of 7.3% during the forecast period of 2023 to 2030.
The market report covers data from the U.S., Canada and Mexico.
